Abstract
Neurons are able to adjust the sensitivity of receptor-mediated processes according to the level of receptor activation. Extrapolating from our knowledge of other cellular proteins, regulation of receptor mRNA availability would provide a highly economical means of achieving this objective. Epidermal growth factor is able to induce long-lasting increases in its receptor binding by increasing receptor mRNA levels, and similar effects have been shown for other growth factors. Studies on G-protein-coupled receptors, in particular using adrenoceptor clones transfected into cultured cell lines, have shown that changes in receptor number are generally associated with an alteration in receptor mRNA content. At the neuromuscular junction, dramatic increases in nicotinic acetylcholine receptor number are achieved by activating receptor subunit gene transcription. Less information is available concerning the regulation of ligand-gated ion channels in the brain.
Overall, the evidence suggests that receptor mRNA levels are frequently controlled by the degree of receptor stimulation. Receptor mRNA levels are therefore likely to be one of the most important control points for both homologous and heterologous regulation of receptor sensitivity.
Similar content being viewed by others
References
Angulo J. A., Coirini H., Ledoux M., and Schumacher M. (1991) Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat. I.Brain Res. 11, 161–166.
Arnauld E., Arsaut J., and Demotes-Mainard J. (1991) Differential plasticity of the dopaminergic D2 receptor mRNA isoforms under haloperidol treatment in the rat anterior pituitary.Neurosci. Lett. 130, 12–16.
Astroff B., Rowlands C., Dickerson R., and Safe S. (1990) 2,3,7,8-TCDD inhibition of 17-beta oestradiol-induced increases in rat uterine epidermal growth factor receptor binding and gene expression.Mol. Cell. Endocrinol. 72, 247–252.
Beguinot B., Hanover J. A., Ito S., Richert N. D., Willingham M. C., and Pastan I. (1985) Phorbol esters induce transient internalisation without degradation of unoccupied epidermal growth factor receptors.Proc. Natl. Acad. Sci. USA 82, 2774–2778.
Belhage B., Meier E., and Schousboe A. (1986) GABA agonists induce the formation of low-affinity GABA receptors on cultured cerebellar granule cells.Neurochem. Res. 11, 599–606.
Belhage B., Hansen G. H., Meier E., and Schousboe A. (1990) Effects of inhibitors of protein synthesis and intracellular transport on the GABA agonist-induced differentiation of cultured cerebellar granule cells.J. Biochem. 55, 1107–1113.
Bernard V., LeMoine C., and Bloch B. (1991) Striatal neurones express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment.Neuroscience 45, 117–126.
Bjorge J. D., Paterson A. J., and Kudlow J. E. (1989) Phorbol ester or EGF stimulate the concurrent accumulation of mRNA for the EGF receptor and its ligand in a breast cancer cell line.J. Biol. Chem. 264, 4021–4027.
Boulter J., Evans K., Goldman D., Martin G., Treco D., Heinemann S., and Patrick J. (1986) Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha subunit.Nature 319, 368–374.
Boulter J., O'Shea-Greenfield A., Durosin R. M., Connolly J. G., Wada E., Jensen A., Gardner P. D., Ballivet M., Dennis E. S., McKinnon D., Meinemann S., and Patrick J. (1990) α3, α5, and β4: three members of the neuronal NaChR family.J. Biol. Chem. 265, 4472–4482.
Bouvier M., Hnatowich M., Collins S., Kobilka B. K., DeBlasi A., Lefkowitz R. J., and Caron M. G. (1988) Expression of a human cDNA encoding the beta2-adrenergic receptor in Chinese hamster fibroblasts: functionality and regulation of the expressed receptors.Mol. Pharmacol. 33, 133–139.
Bouvier M., Collins S., O'Dowd B. F., Campbell P. T., DeBlasi A., Kobilka B. K., MacGregor C., Irons G. P., Caron M. G., and Lefkowitz R. J. (1989) Two distinct pathways for cAMP-mediated down-regulation of the beta2-adrenergic receptor.J. Biol. Chem. 264, 16,786–16,792.
Boyd R. T., Jacob M. H., Coutourier S., Ballivet M., and Berg D. K. (1988) Expression and regulation of neural acetylcholine receptor mRNA in chick ciliary ganglia.Neuron 1, 495–502.
Brene S., Lindefors N., Herrera-Marschitz M., and Persson H. (1990) Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine-deafferented caudate-putamen.Expl. Brain. Res. 83, 96–104.
Brenner H. R., Witzemann V., and Sakmann B. (1990) Imprinting of acetylcholine receptor mRNA accumulation in mammalian neuromuscular synapses.Nature 344, 544–547.
Carpenter G., and Cohen S. (1990) Epidermal growth factor.J. Biol. Chem. 265, 7709–7712.
Clark A. J. L., Ishii S., Richert N., Merlino G. T., and Pastan I. (1985) Epidermal growth factor regulates the expression of its own receptor.Proc. Natl. Acad. Sci. USA 82, 8374–8378.
Coirini H., Schumacher M., Angulo J. A., and McEwen B. S. (1990) Increase in striatal D2 receptor mRNA after lesions or haloperidol treatment.Eur. J. Pharmacol. 186, 369–371.
Collins S., Bouvier M., Bolanowski M. A., Caron M. G., and Lefkowitz R. J. (1989) cAMP stimulates transcription of the beta2-adrenergic receptor gene in response to short-term agonist exposure.Proc. Natl. Acad. Sci. USA 86, 4853–4857.
Deneris E. S., Boulter J., Swanson L. W., Patrick J., and Heinemann S. (1989) Beta3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain.J. Biol. Chem. 24, 6268–6272.
Devedjian J. C., Fargues M., Denis-Pouxviel C., Daviaud D., Prats H., and Paris H. (1991) Regulation of the alpha2-adrenergic receptor in the HT29 cell line.J. Biol. Chem. 266, 14,359–14,366.
Doherty P., Seaton P., Flanigan T. P., and Walsh F. S. (1988) Factors controlling the expression of the NGF receptor in PC12 cells.Neurosci. Lett.,92, 222–227.
Duclert A., Piette J., and Changeux J-P. (1990) Induction of acetylcholine receptor alpha subunit gene expression in chicken myotubes by blocking electrical activity requires ongoing protein synthesis.Proc. Natl. Acad. Sci. USA 87, 1391–1395.
Duvoisin R. M., Deneris E. S., Patrick J., and Heinemann S. (1989) The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit, beta 4.Neuron,3, 487–496.
Earp H. S., Hepler J. R., Petch L. A., Miller A., Berry A. R., Harris J., Raymond V. W., McCune B. K., Lee L. W., Grisham J. W., and Harden T. K. (1988) Epidermal growth factor and hormones stimulate PI hydrolysis and increase egf receptor protein synthesis and mRNA levels in rat liver epithelial cells.J. Biol. Chem. 263, 13,868–13,874.
Evans S., Goldman D., Heinemann S., and Patrick J. (1987) Muscle acetylcholine receptor biosynthesis: regulation by transcript availability.J. Biol. Chem. 262, 4911–4916.
Fontaine B. and Changeux J.-P. (1989) Localization of nicotinic acetylcholine receptor alpha-subunit transcripts during myogenesis and motor endplate development in the chick.J. Cell. Biol. 108, 1025–1037.
Fukamauchi F., Hough C., and Chuang D.-M. (1991) Expression and agonist-induced downregulation of mRNAs of m2 and m3 muscarinic acetylcholine receptors in cultured cerebellar granule cells.J. Neurochem. 56, 716–719.
Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J., and Sibley J. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurones.Science 2, 1429–1432.
Giros B., Sokoloff P., Martres M. P., Riou J. F., Emorine L. F., and Schwartz J. C. (1989) Alternative splicing directs the expression of two D2 dopamine receptor isoforms.Nature 342, 923–926.
Goldman D., Boulter J., Heinemann S., and Patrick J. (1985) Muscle denervation increases the levels of two mRNAs encoding the acetylcholine receptor alpha subunit.J. Neurosci. 5, 2553–2558.
Goldman D., Deneris E., Luyten W., Kochhar A., Patrick J., and Heinemann S. (1987) Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system.Cell 48, 965–973.
Goldman D., Brenner H. R., and Heinemann S. (1988) Acetylcholine receptor α,β,γ and δ subunit mRNA levels are regulated by muscle activity.Neuron 1, 329–333.
Gu Y. and Hall Z. W. (1988) Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscleNeuron 1, 117–125.
Guest S. J., Hadcock J. R., Watkins D. C., and Malbon C. C. (1990) Beta1 and beta2 adrenergic receptor expression in differentiating 3T3-L1 cells.J. Biol. Chem. 26, 5370–5375.
Hadcock J. R. and Malbon C. C. (1988) Down-regulation of beta-adrenergic receptors: agonist-induced reduction in receptor mRNA levels.Proc. Natl. Acad. Sci. USA 85, 5021–5025.
Hadcock J. R., Ros M., and Malbon C. C. (1989a) Agonist regulation of beta-adrenergic receptor mRNA: analysis in S49 mouse lymphoma mutants.J. Biol. Chem. 264, 13,956–13,961.
Hadcock J. R., Wang H.-Y., and Malbon C. C. (1989b) Agonist-induced destabilisation of beta-adrenergic receptor mRNA.J. Biol. Chem. 264, 19,928–19,933.
Haley J. D., and Waterfield M. D. (1991) Contributory effects ofde novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis.J. Biol. Chem. 266, 1746–1753.
Hargrave J. L. and Schmidt F. H. (1989) The role of mRNA and protein stability in gene expression.FASEB J. 3, 2360–2378.
Hatada E. N., McClain D. A., Potter E., Ullrich A., and Olefsky K. M. (1989) Effects of growth and insulin treatment on the levels of insulin receptors and their mRNA in HepG2 cells.J. Biol. Chem. 264, 6741–6747.
Haverstick D. M. and Bannon M. J. (1989) Evidence for dual mechanisms involved in metamphatamine-induced increases in striatal preprotachykinin mRNA.J. Biol. Chem. 264, 13,140–13,144.
Heninger C., Saito N., Tallman J. F., Garrett K. M., Vitek M. P., Duman R. S., and Gallagher D. W. (1990) Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain.J. Mol. Neurosci. 2, 101–107.
Hirouchi M., Ohkuma S., and Kuriyuma K. (1992) Muscimol-induced reduction of GABA receptor alpha-subunit mRNA in primary cultured cortical neurons.Mol. Brain Res. 15, 327–331.
Hoffman Y. M., Peegel H., Sprock M. J., Zhang Q. Y., and Menon K. M. (1991) Evidence that human LH/hCG receptor downregulation involves decreased levels of mRNA.Endocrinology 128, 388–393.
Hough C. and Chuang D.-M. (1990) Differential down-regulation of beta1 and beta2 adrenergic receptor mRNA in C6 glioma cells.Biochem. Biophys. Res. Comm. 170, 46–52.
Huber G. K., Concepcion E. S., Graves P. N., and Davies T. F. (1991) Positive regulation of human TSH receptor mRNA by TSH.J. Clin. Endocrinol. Metab. 72, 1394–1396.
Izzo N. J., Seidman C. E., Collins S., and Colucci W. S. (1990) Alpha1-adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells.Proc. Natl. Acad. Sci. USA 87, 6268–6271.
Jacob M. H. and Berg D. K. (1987) Effects of preganglionic denevation and postganglionic axotomy on acetylcholine receptors in the chick ciliary ganglion.J. Cell. Biol. 105, 1847–1854.
Jaramillo F., Vicini S., and Schuetze S. M. (1988) Embryonic acetylcholine receptors guarantee spontaneous contractions in rat developing muscle.Nature 335, 66–68.
Kang I. and Miller E. G. (1991) Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration.Br. J. Pharmacol. 103, 1285–1287.
Kesavan P., Das P., Kern J., and Das M. (1990) Regulation of stability and synthesis of EGF-receptor mRNAs encoding the intact and truncated forms.Oncogene 5, 483–488.
Klarsfeld A. and Changeux J. P. (1985) Activity regulates the level of acetylcholine receptor alpha subunit mRNA in cultured chick myotubes.Proc. Natl. Acad. Sci. USA 82, 4558–4562.
Klarsfeld A., Laufer R., Fontaine B., Devillers-Thiery A., Dubreuil C., and Changeux J. P. (1989) Regulation of muscle AChR alpha subunit gene expression by electrical activity.Neuron 2, 1229–1236.
LaPolt P. S., Oikawa M., Xiao-Chi J., Dargan K., and Hsueh J. W. (1990) Gondotropin-induced up- and down-regulation of rat ovarian LH/CG receptor mRNA levels.Endocrinology 125, 3277–3281.
Lefkowitz R. J., Hausdorff W. P., and Caron M. G. (1990) Role of phosphorylation in desensitisation of the β-adrenoceptor.Trends in Pharmacol. Sci. 11, 190–194.
Lew J. Y., Zazadzka D., Feigenblum D., Tang D., Filer D., Benedatto P., and Goldstein M. (1990) Regulation and molecular characterisation of dopamine D2 receptors in a prolactin-secreting anterior pituitary tumour.Eur. J. Pharmacol. 188, 329–334.
Linden D. C. and Fambrough D. M. (1979) Biosynthesis and degradation of acetylcholine receptors in rat skeletal muscles.Neuroscience 4, 527–538.
Lindenbaum M. H., Carbonetto S., Grosveld F., Flavell D., and Mushynski W. E. (1988) Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC12 cells.J. Biol. Chem. 263, 5662–5667.
McKinney M. and Robbins M. (1992) Chronic atropine administration up-regulates rat cortical muscarinic m1 and m2 receptor mRNAs.Mol. Brain Res. 12, 39–45.
Malosio M-L., Grenningloh G., Kuhse J., Schmieden V., Schmitt B., Prior P., and Betz H. (1991) Alternative splicing generates two variants of the {ie203-1} subunit of the inhibitory glycine receptor.J. Biol. Chem. 266, 2048–2053.
Maloteaux J.-M., Octave J.-N., Gossuin A., Laterre C., and Trouet A. (1987) Down-regulation of GABAA receptors in vitro.Eur. J. Pharmacol. 144, 173–183.
Merlie J. P., Isenberg K. E., Russell S. D., and Sanes J. R. (1984) Denervation supersensitivity in skeletal muscle: analysis with a cloned cDNA probe.J. Cell. Biol. 99, 332–335.
Miller F. D., Mathew T. C., and Toma J. G. (1991) Regulation of nerve growth factor receptor gene expression by nerve growth factor in the developing peripheral nervous system.J. Cell. Biol. 112, 303–312.
Miller L. G., Greenblatt D. J., Barnhill J. G., and Shader R.I. (1988) Chronic benzodiazepine administration I: tolerance is associated with benzodiazepine receptor down-regulation and decreased GABAA receptor function.J. Pharmacol. Exp. Ther. 246, 170–177.
Mishina M., Takai T., Imoto K., Noda M., Takahashi T., Numa S., Methfessel C., and Sakmann B. (1986) Molecular distinction between fetal and adult forms of muscle acetylcholine receptor.Nature 321, 406–411.
Mohler H., Okada T., and Enna S. J. (1978) Benzodiazepine and neurotransmitter receptor binding in rat brain after chronic administration of diazepam or phenobarbital.Brain Res. 156, 391–395.
Mokuno K., Sobue G., Reddy U. R., Wurzer J., Kreider B., Hotta H., Baron P., Ross A., and Pleasure D. (1988) Regulation of Schwann cell nerve growth factor receptor by cAMP.J. Neurosci. Res. 21, 465–472.
Montpied P., Ginns E. I., Martin B. M., Roca D., Farb D. H., and Paul S. M. (1991) GABA induces a receptor-mediated reduction in GABAA receptor subunit mRNA in embryonic chick neurones in culture.J. Biol. Chem. 266, 6011–6014.
Morris B. J., Hicks A., Wisden W., Darlison M. G., Hunt S. P., and Barnard E. A. (1990) Distinct regional distribution of nicotinic acetylcholine receptor subunit mRNAs in chick brain.Mol. Brain Res. 7, 305–315.
Morris B. J. and Millan M. J. (1991) Inability of an opioid antagonist lacking negative intrinsic activity to induce opioid receptor up-regulationin vivo.Br. J. Pharmacol. 102, 883–886.
Morris B. J. and Barnard E. A. (1991) Selective induction of nicotinic receptor subunit gene expression following chronic nicotine administration.Br. J. Pharmacol. 102, 148P.
Morris G. M., Hadcock J. R., and Malbon C. C. (1991) Cross-regulation between G-protein-coupled receptors.J. Biol. Chem. 266, 2233–2238.
Moss S. J., Beeson D. M. W., Jackson J. F., Darlison M. G., and Barnard E. A. (1987) Differential expression of nicotinicacetylcholine receptor genes in innervated and denervated chicken muscle.EMBO J. 6, 3917–3921.
Nef P., Oneyser C., Alliod C., Coutourier S., and Ballivet M. (1988) Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors.EMBO J. 7, 595–601.
O'Donovan M. C., Buckland P. R., and McGuffin P. (1992a) Levels of GABAA receptor subunit mRNA in rat brain following flurazepam treatment.J. Psychopharmacol. 6, 364–369.
O'Donovan M. C., Buckland P. R., and McGuffin P. (1992b) Bidirectional changes in the levels of mRNAs encoding GABAA receptor alpha subunits after flurazepam treatment.Eur. J. Pharmacol. 226, 335–341.
Oron Y., Straub R. E., Traktman P., and Gershenghorn M. C. (1987) Decreased TRH receptor mRNA activity precedes homologous down-regulation: assay in oocytes.Science 238, 1406–1408.
Papa V., Hartmann K., Rosenthal S. M., Maddux B. A., Siiteri P. K., and Goldfine I. D. (1991) Progestins induce down-regulation of insulin-like growth factor-I receptors in human breast cancer cells.Mol. Endocrinol. 5, 709–717.
Popot J.-L. and Changeux J. P. (1984) Nicotinic receptor of acetylcholine: structure of an oligomeric integral membrane protein.Physiol. Rev. 64, 1162–1239.
Rosenthal S. M., Brown E. J., Brunetti A., and Goldfine I. D. (1991) Fibroblast growth factor inhibits IGF-II gene expression and increases IGF-I receptor abundance in BC3H-1 muscle cells.Mol. Endocrinol. 5, 678–684.
Roca D. J., Rozenberg I., Farrant M., and Farb D. H. (1990) Chronic agonist exposure induces down-regulation and allosteric uncoupling of the GABA/benzodiazepine receptor complex.Mol. Pharmacol. 37, 37–43.
Rouiller D. G., McKeon C., Taylor S. I., and Gorden P. (1988) Hormonal regulation of insulin receptor gene expression.J. Biol. Chem. 263, 13,185–13,190.
Saji M., Ikuyama S., Akamizu T., and Kohn L. D. (1991) Increases in cytosolic Ca2+ downregulate TSH receptor gene expression.Biochem. Biophys. Res. Comm. 176, 94–101.
Sakaue M. and Hoffman B. B. (1991) cAMP regulates transcription of the alpha2 adrenergic receptor gene in HT-29 cells.J. Biol. Chem. 266, 5743–5749.
Schieh B. H., Ballivet M., and Scmidt J. (1988) Acetylcholine receptor synthesis rate and levels of receptor subunit mRNAs in chick muscle.Neuroscience 24, 175–187.
Schofield P. R., Darlison M. G., Fujita N., Burt D. R., Stephenson F. A., Rodriguez H., Rhee L. M., Ramachandran J., Reale V., Glencorse T. A., Seeburg P. H., and Barnard E. A. (1987) Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super family.Nature 328, 221–227.
Schuetze S. M. and Role L. W. (1987) Developmental regulation on nicotinic acetylcholine receptors.Ann. Rev. Neurosci. 10, 403–457.
Schwartz R. D. and Kellar K. J. (1983) Nicotinic cholinergic receptor binding sites in brain: regulation in vivo.Science 220, 214–216.
Senba E., Simmons D. M., Wada E., Wada K., and Swanson L. W. (1990) RNA levels of neuronal nicotinic acetylcholine receptor subunits are differentially regulated in axotomised facial motoneurones.Mol. Brain Res. 8, 349–353.
Smith J. D. and Liu A. Y. (1988) Increased turnover of the messenger RNA encoding tyrosine amino-transferase can account for the desensitization and de-induction by 8-bromo-cyclic AMP treatment and removal.EMBO J. 7, 3711–3716.
Soejima M. and Noma A. (1984) Muscarinic activation of K+-channels in atrial cell membranes.Pflugers Arch. 400, 424–431.
Sommer B., Keinanen K., Verdoorn T., Wisden W., Burnashev N., Herb A., Koehler M., Takagi T., Sakmann B., and Seeburg P. H. (1990) Flip and Flop: a cell-specific functional switch in glutamate-operated channels of the CNS.Science 249, 1580–1584.
Srivastava L. K., Morency M. A., Bajwa S. B., and Mishra R. K. (1990) Effect of haloperidol in expression of dopamine D2 receptor mRNAs in rat brain.J. Molec. Neurosci. 2, 155–161.
Steinhilber W., Poensgen J., Rausch U., Kern H., and Scheele G. A. (1988) Translational control of anionic trypsinogen and amylase synthesis in rat pancreas in response to caerulein stimulation.Proc. Natl. Acad. Sci. USA 85, 6597–6601.
Tehrani M. H. J. and Barnes E. M. (1988) GABA downregulates the GABA/benzodiazepine receptor complex in developing cerebral neurons.Neurosci. Lett. 87, 288–292.
Theodorakis N. G., Banerji S. S., and Morimoto R. I. (1988) HSP70 mRNA translation in chicken reticulocytes is regulated at the level of elongation.J. Biol. Chem. 263, 14,579–14,585.
Tietz E. I., Rosenberg H. C., and Chiu T. H. (1986) Autoradiographic localisation of benzodiazepine receptor down-regulation.J. Pharmacol. Exp. Ther. 236, 284–293.
Tsay H.-J. and Schmidt J. (1989) Skeletal muscle denervation activates acetylcholine receptor genes.J. Cell. Biol. 108, 1523–1526.
van Tol H. H. M., Riva M., Civelli O., and Creese I. (1990) Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level.Neurosci. Lett. 111, 303–308.
Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., and Swanson L. W. (1989) Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system.J. Comp. Neurol. 284, 314–335.
Wang H., Segaloff D. L., and Ascoli M. (1991) Epidermal growth factor and phorbol esters reduce the levels of the mRNA for the LH/CG receptor.Endocrinology 128, 2651–2653.
Whiting P., McKernan R. M., and Iversen L. L. (1990) Another mechanism for creating diversity in GABAA receptors: RNA splicing directs expression of two forms of γ2 subunit.Proc. Natl. Acad. Sci. USA 87, 9966–9970.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morris, B.J. Control of receptor sensitivity at the mRNA level. Mol Neurobiol 7, 189–205 (1993). https://doi.org/10.1007/BF02769175
Issue Date:
DOI: https://doi.org/10.1007/BF02769175